You are here

Bonvests, Tai Tak bow out as Cordlife's substantial shareholders

Stake sales will see emergence of Chinese retail giant Nanjing Xinjiekou as major shareholder

BIGGER ASPIRATIONS: Nanjing Xinjiekou announced on the stock exchange that its board had approved the purchase of 51.87m shares in Cordlife to "aid" the firm's expansion into the cord blood business in South-east Asia.


THE "play" by Cordlife Group's two longtime substantial shareholders - less than three months after they demanded board seats in the cord-blood banking firm (they got their way shortly after) - has taken an unexpected yet possibly promising turn.

Singapore-listed Bonvests...